# Google Ads for TRT clinics and telehealth brands

Checked against the platform policy pages October 5, 2026 · By Michael Borgia, MedScale Health

## Short answer

As of October 2026, a TRT telehealth brand needs Google's prescription drug services certification, backed by LegitScript in the US, before its prescription-drug ads serve. Google decides who that covers from the ads, the site and the app, so consult-led ads that don't name a drug are still judged on the whole site; certification is the path. Enclomiphene and peptides stay off the account even after certification because they are not FDA-approved drugs. MedScale Health runs TRT telehealth on Google in that order: certification first, with Meta and the landing pages built while it runs, then clinic, treatment and drug-term campaigns on the certified domain.

## What this means for you

- Certification comes first for a TRT telehealth prescriber. Online TRT clinic and testosterone therapy online are good keywords, but the site behind them is what Google judges.
- Certification is two applications in sequence: LegitScript first, Google second. Budget weeks, not days, and run Meta while it moves.
- Enclomiphene, hCG for TRT and peptides are unapproved-pharmaceutical terms on Google. They cannot be advertised with or without certification.
- Testosterone is a controlled substance, so landing pages state the prescribing and telemedicine requirements plainly. Google and LegitScript both read for that.
- The conversion is labs ordered or intake completed in a served state, then a prescriber visit. Clicks on drug terms from price-shoppers are excluded by negatives.

## What each platform allows

### Google Ads, before certification: cert (LegitScript)

Rejected:
- Prescription-drug service ads from a telemedicine provider that isn't certified
- Testosterone, cypionate, enclomiphene or any drug term as a keyword
- Claims about energy, muscle, libido or performance outcomes

Account risk:
- Peptides or other unapproved substances anywhere the ad can reach
- Trademark bidding on drug brands
- New accounts or domains opened to get around a disapproval

Requires:
- Google's prescription drug services certification before prescription-drug ads serve; Google decides coverage from the ads, the site and the app
- Consult-led ads that don't name a drug are still judged on the whole site, so certification is the path

How we run it: While certification runs, we build the landing pages to the standard Google and LegitScript review against, and run Meta on the lab-first offer, which Meta allows for general telehealth services without authorization.

Source: https://support.google.com/adspolicy/answer/15598647 (checked October 5, 2026)

### Google Ads, with certification: cert (LegitScript)

Rejected:
- Presenting compounded testosterone or enclomiphene as FDA-approved
- Outcome claims

Account risk:
- Losing LegitScript certification, which revokes Google's
- Drifting from telehealth positioning to pharmacy positioning after approval

Requires:
- LegitScript Healthcare Merchant Certification for the telemedicine provider and its domain, then Google's Healthcare and medicines certification filed for prescription drug services with the certified domain and customer ID

How we run it: Clinic, treatment and testosterone keyword campaigns launch on the certified domain, with the controlled-substance and telemedicine requirements stated on the page and no unapproved products anywhere in the account.

Source: https://support.google.com/adspolicy/answer/15598647 (checked October 5, 2026)

### Meta (for comparison): cert (LegitScript)

Rejected:
- "Low T?" personal-attribute hooks
- Drug names without certification and authorization
- Shirtless or idealized-body imagery

Account risk:
- Pharmacy-style landing pages
- Enclomiphene or peptides as products

Requires:
- LegitScript certification and Meta authorization before naming testosterone; clinic-service ads run without it

How we run it: The same lab-first, provider-led offer, aimed 18 and over, with medication named on the page rather than in the ad until authorization is active.

Source: https://transparency.meta.com/policies/ad-standards/restricted-goods-services/drugs-pharmaceuticals/ (checked September 16, 2026)

## What Google's rules say about testosterone telehealth

Two Google policies decide the category. The prescription drug services rule requires online pharmacies and telemedicine providers to be certified before their ads serve, and Google decides who is covered from the content of the ads, the site and the app. The restricted drug terms rule changed on October 29, 2025: in the US, drug terms in ad text and on landing pages no longer need certification, but keyword-targeting them does, and certification is still required for telemedicine providers. For a US TRT telehealth brand that means certification first. Separately, Google's unapproved pharmaceuticals rule blocks enclomiphene and peptides outright, because neither is an FDA-approved drug; certification does not change that. And because testosterone is a controlled substance, Google's reviewers and LegitScript's analysts both look for the prescribing and telemedicine requirements to be stated on the page rather than implied.

## While certification runs: pages, Meta and the keyword plan

Certification takes weeks, and the time is not wasted. The landing pages are built to the standard Google and LegitScript both review: program and lab panel first, medication options lower down, controlled-substance and telemedicine requirements stated, medical director named. Meta runs on the lab-first offer, because Meta allows ads that promote telehealth services generally without authorization. The Google keyword plan is built and ready: clinic intent (online TRT clinic, TRT telehealth), treatment intent (testosterone therapy online, men's hormone therapy telehealth), process intent (at-home testosterone test, TRT labs online), state intent where the brand is licensed, and negatives that exclude enclomiphene, peptides and price-comparison terms.

## Certification: LegitScript, then Google

LegitScript's Healthcare Merchant Certification is one application per website: $975 to apply and $2,150 a year, with expedited review available for $2,500. Its review examines licensing, prescribing practice for a controlled substance, privacy and marketing claims, and answering its questions quickly is the single biggest factor in how long it takes. Once approved, Google's Healthcare and medicines certification is a separate online application filed with the customer ID and the certified domain. Then the clinic, treatment and testosterone keyword campaigns launch on the certified domain, with landing pages that state the compounding status of any compounded testosterone and the prescriber oversight.

## Ad copy and landing pages that clear both reviews

Copy that passes is about the process and the provider: labs, visit, prescription if appropriate, follow-up, price. It avoids second-person claims about the reader's energy or performance, which Google reads as unsubstantiated outcome claims and Meta reads as personal attributes. The landing page leads with the program and the lab panel, explains medication options in a lower section, states the controlled-substance and telemedicine requirements in plain language, names the medical director, and carries the certification seal in the footer once it exists. Enclomiphene and hCG, where the brand offers them, are explained on the page as options discussed with the prescriber, never as products with prices, and peptides are kept off every page an ad can reach. A page built this way is ready for LegitScript's analyst and Google's reviewer without being rebuilt.

## Measurement and how MedScale Health runs it

The metrics are cost per qualified lead (intake completed in a state the brand serves), labs ordered, prescriber visits booked, prescriptions issued as reported by the intake platform, and ninety-day retention by campaign. The click ID is carried into the intake platform inside a bridge token and each downstream event is sent back server-side with it attached, so the campaign is credited with the patient and no health detail is sent to Google. Week one is the policy read of the account, pages and pixel, with controlled-substance flags listed separately. The LegitScript application starts in parallel where the brand doesn't hold it. Week two puts tracking live, and Meta on the lab-first offer launches by Day 14. Google follows once certification clears. If the account is currently suspended for drug-term or unapproved-substance reasons, the Ad Account Rescue diagnoses the flag inside twelve hours and rebuilds and appeals inside seventy-two.

## Results from the accounts

Anonymised results from telehealth brands and clinics that run on our tracking. Names are withheld. Results vary by brand, offer and budget.

**Twice the rate to checkout**

A men's telehealth brand ran two routes from its ads in the same weeks. One reached checkout at 2.7%. The other reached it at 1.3%.

**Booking counts Google can bid on**

For a men's health clinic group, the bookings our server-side tracking sent to Google matched the group's own tag within 5% over two weeks: 156 against 164.

Every case study: https://medscale.health/results

## FAQ

**Can a TRT telehealth brand run Google Ads without LegitScript?**

Plan on certification first. Google requires telemedicine providers to be certified before prescription-drug ads serve, and it decides who is covered from the ads, the site and the app. Consult-led ads that don't name a drug are still judged on the whole site, so a TRT prescriber running uncertified is exposed. Meta is different: ads that promote the telehealth service generally run without authorization, so Meta carries the launch while certification moves.

**Does certification let us advertise enclomiphene?**

No. Enclomiphene is not an FDA-approved drug, so it falls under Google's unapproved pharmaceuticals rule regardless of certification, and the same applies to peptides. A brand that offers enclomiphene explains it on the page as an option discussed with the prescriber and never names it in ads, keywords or as a product for sale.

**How long does Google certification take for TRT?**

LegitScript's review takes weeks and depends on documentation and response speed; expedited review is offered for $2,500 on top of the standard fees. Google's certification is a separate application after LegitScript approval and is not instant either. Plan for a period of Meta-only advertising while both run, rather than an uncertified Google launch.

**Why does Google flag our testosterone landing page even though our ads are clean?**

Google reviews the landing page as part of the ad. A page that names testosterone with a price and an order button reads as a pharmacy, which pulls every ad pointing at it under the prescription-drug rules. Lead with the program and the labs, move medication options below the fold, state the prescribing requirements, and remove anything that reads as a drug for sale.

**How do you attribute a prescription that happens in our intake platform?**

The click ID travels into the intake platform inside a bridge token, and the visit and prescription events are sent back server-side with that token attached. Google receives a generic conversion with the click ID and no health detail; the brand's report shows cost per qualified lead through prescriptions issued by campaign and state.

**Does an in-person TRT clinic need certification for Google Ads?**

Not for clinic keywords. An in-person clinic can bid on TRT clinic near me, testosterone clinic, men's health clinic or hormone clinic plus a city, and in the US it can name testosterone in its ad text and on its landing page without certification. Keyword-targeting testosterone or another drug term needs Google's certification. Once the clinic prescribes online it is a telemedicine provider, and LegitScript and Google certification come before prescription-drug ads serve.

**What does the DEA telemedicine rule mean for TRT Google Ads?**

Testosterone is a Schedule III controlled substance, and prescribing it by telemedicine without a prior in-person medical evaluation relies on DEA flexibilities that the current extension keeps in effect through December 31, 2026. For ads, that means no copy that promises a prescription or an online-only start, and landing pages that state the prescribing and telemedicine requirements plainly. MedScale builds offers that hold up if the rule changes: labs first, then a provider visit.

**How much does Google Ads management for a TRT brand cost?**

The fee is set by scope after a free Growth Audit: which platforms, how many offers and states, and how much new creative each month. It runs month to month. Ad spend is separate and paid to Google from your own account, which stays in your name. For a telehealth brand, LegitScript's fees are separate again and paid to LegitScript. The audit returns a written plan for ads, landing pages and tracking, so the scope is clear before you commit.

Canonical page: https://medscale.health/telehealth/trt-mens-health/google-ads